Kopran (KOPRAN) | Stock Overview & Key Data
Kopran Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹370.45 on December 27, 2021
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Kopran
KOPRAN
|
7.78B Small-cap | 0.76% | 17.31% | 61.61% | 39.40% | 21.01% | -7.55% | -0.93% | -8.88% | 248.30% | 693.19% | 358.69% |
|
GlaxoSmithKline
GLAXO
|
422.67B Large-cap | -3.19% | -13.28% | -11.99% | -17.96% | -13.88% | -35.63% | 50.14% | 45.44% | -39.87% | -9.78% | 324.98% |
|
Pfizer
PFIZER
|
218.82B Large-cap | -0.22% | -8.81% | -4.87% | -9.94% | -8.09% | -23.35% | 16.94% | -16.55% | 139.64% | 232.33% | 479.18% |
|
Senores
SENORES
|
41.04B Small-cap | 27.43% | 22.17% | 72.40% | 57.40% | 55.27% | 131.62% | 125.07% | 125.07% | 125.07% | 125.07% | 125.07% |
|
Sms Pharmaceuticals
SMSPHARMA
|
37.15B Small-cap | 2.49% | -5.59% | 3.24% | 16.68% | 20.59% | 54.90% | 314.99% | 124.70% | 340.29% | 1,909.70% | 1,070.48% |
|
NGL Fine-Chem
NGLFINE
|
13.81B Small-cap | 17.19% | 32.28% | 42.63% | 133.76% | 122.63% | 190.36% | 86.41% | 63.13% | 63.13% | 63.13% | 63.13% |
Ownership & Short Interest
Calculate Your Kopran Investment Returns
Long-Term Investment Performance Analysis
Kopran stock price in Aug 2016 was ₹51.20, A ₹1,000.00 lump sum investment in Kopran made 9 years ago would be worth approximately ₹3,581.64 today, representing a outstanding return of 258.16%. This translates to an annualized return (CAGR) of 13.80%.
9 Years 10 Months Investment Scenario (Aug 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is KOPRAN's 52-week high and low?
- In the last 52 weeks, Kopran reached a high of ₹219.00 (on May 29, 2026) and a low of ₹107.00 (on March 30, 2026).
- What is the market cap and P/E ratio for KOPRAN?
- Curious about Kopran's size and valuation? Its market capitalization stands at 7.78B. When it comes to valuation, the P/E ratio (trailing twelve months) is 47.13, and the forward P/E (looking ahead) is 28.43.
- Does KOPRAN pay dividends? If so, what's the yield?
- Yes, Kopran is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.74%, and the company has paid an average of ₹3.00 per share annually over the past 3 years.
- Who are Kopran's main competitors or similar companies to consider before investing?
When looking at Kopran, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return GlaxoSmithKline
GLAXO422.67B Healthcare Drug Manufacturers - General -35.63% 50.14% Pfizer
PFIZER218.82B Healthcare Drug Manufacturers - General -23.35% 16.94% Senores
SENORES41.04B Healthcare Drug Manufacturers - General 131.62% 125.07% Sms Pharmaceuticals
SMSPHARMA37.15B Healthcare Drug Manufacturers - General 54.90% 314.99% NGL Fine-Chem
NGLFINE13.81B Healthcare Drug Manufacturers - General 190.36% 86.41% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Kopran Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Kopran's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 7.44%, the Debt to Equity ratio from the most recent quarter is 31.30, and its Gross Profit Margin stands at 32.54%.
- What is the recent revenue and earnings growth for KOPRAN?
- Looking at Kopran's growth, its revenue over the trailing twelve months (TTM) was INR6B. Compared to the same quarter last year (YoY), quarterly revenue grew by 16.90%, and quarterly earnings saw a YoY growth of -10.20%.
- How much of KOPRAN stock is held by insiders and institutions?
- Wondering who owns Kopran stock? Company insiders (like executives and directors) hold about 47.44% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.25%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.